A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

Clinical trial NCT07477756 · COMPLETED

Trial details

NCT number: NCT07477756
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2024-09-04
Primary completion: 2025-03-14
Enrollment: 1247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.